Back to search

Germany· DE-A57-739f12b938e183c0

Propafenonhydrochlorid Heumann

A propafenone product containing propafenone hydrochloride, registered in Germany by Heumann Pharma Gmbh & Co. Generica Kg. The same ATC class is registered in 16 of our 19 countries.

ATC C01BC03

Checked against EMA Article 57 (European Union) on

Informational only — not a medical device.

SOURCE REGISTER · DEEMA Article 57 (European Union)normalisedPropafenonhydrochlorid HeumannATCC01BC03REGISTER NO.DE-A57-739f12b938e183…PACKS LISTED0CHECKEDSeptember 30, 2026

Where it is registered

Propafenone is registered in 16 of 19 countries.

Countries holding a registration under ATC C01BC03 (propafenone), each read from that country’s own register.

  • This record: Germany, from EMA Article 57 (European Union)
  • 9 of them publish a price we can compare per daily dose

Propafenone · ATC C01BC03

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of propafenone costs, country by country.

Normalised to the WHO defined daily dose (0.5 g), the median price runs from $0.23 in France to $0.68 in United States — a ×2.9 gap.

  • 4 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail

Propafenone · price per daily dose (0.5 g)

USD · FX 28 Sept 2026

  • US United States$0.68 (acquisition cost)
  • IT Italy$0.45
  • ES Spain$0.28
  • FR France$0.23
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

EMA Article 57 (European Union)
Active substance
Propafenone Hydrochloride
Manufacturer
Heumann Pharma Gmbh & Co. Generica Kg
Country
Germany (DE)
ATC code
C01BC03
ATC class
Propafenone
Defined daily dose
0.5 g, O
Reimbursed
Not published by this register
Source register
EMA Article 57 (European Union)
Last checked
September 30, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

311 interactions on record for propafenone.

Graded by severity as the source publishes them — 47 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Propafenone · interactions on record

311 records

  • 47 severe
  • 192 moderate
  • 7 minor
  • 19 info

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • EliglustatA16AX10severe

46 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Propafenone in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All propafenone products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

  • Austria · Propafenon Accord, Rytmonorma
  • Belgium · Rytmonorm
  • Bulgaria · Пропастад, Пропафенон Алкалоид
  • Cyprus · Propafenone Hydrochloride Accord Healthcare, Ρυθμονόρμ
  • Czechia · Propafenon Al, Propanorm
  • Denmark · Rytmonorm
  • Estonia · Propafenone Accord, Propanorm
  • Spain · Rytmonorm
  • France · Propafenone Accord, Propafenone Viatris
  • United Kingdom (Northern Ireland) · Arythmol, Propafenone Hydrochloride Accord
  • Greece · Ρυθμονόρμ, Ρυθμονορμ Sr
  • Croatia · Propafenon Alkaloid, Rytmonorm
  • Hungary · Propafenon Al, Propafenon Pharmavit
  • Ireland · Propafenone Hydrochloride Accord Healthcare Ireland
  • Italy · Propafenone Accord, Propafenone Doc Generici
  • Lithuania · Propafenone Accord, Propanorm
  • Luxembourg · Rytmonorm
  • Latvia · Propafenone Accord, Rytmonorm
  • Malta · Propafenone Hydrochloride Accord Healthcare
  • Netherlands · Rytmonorm
  • Poland · Polfenon, Rytmonorm
  • Portugal · Propafenona Accord, Rytmonorm
  • Romania · Propafenonă Al, Propafenonă Arena
  • Sweden · Rytmonorm
  • Slovenia · Propafenon Alkaloid-Int, Rytmonorm
  • Slovakia · Propanorm, Rytmonorm

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/aa69ff33-fa4c-44a1-8e67-20f25a027b30
GET /v1/drugs/aa69ff33-fa4c-44a1-8e67-20f25a027b30?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "pzn": null,
  "route": "Oral Use",
  "source": "ema_art57_de",
  "ma_number": null,
  "substance": "Propafenone Hydrochloride",
  "atc_from_source": null,
  "authorisation_country": "Germany"
}

See everything about propafenone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.